Love Pharma Inc (TSE:JOLT) has released an update.
Jolt Health Inc. has successfully completed a non-brokered private financing round, raising $500,000 through the issuance of 50 million units priced at $0.01 each. These funds are earmarked for general working capital needs and debt repayment, with restrictions on paying officer salaries or funding investor relations. The financing terms include common shares and warrants with potential for accelerated expiry if the company’s share price reaches certain milestones.
For further insights into TSE:JOLT stock, check out TipRanks’ Stock Analysis page.
